Why This Pharmaceutical Stock Jumped Almost 100% This Week
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Considering the years of retirement is essential for effective financial planning. Evaluate your needs and prepare for a comfortable future.
21,046 articlesA mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
New York’s decision to pause large-scale data center projects up to a year changes the playing field for cloud giants...
FactSet (FDS) investors are eyeing the Q3 2026 earnings with questions about growth, margins, and product strategy. T...
When a MongoDB director sells a sizable block of shares, investors pause to weigh the meaning. This article breaks do...
Toast is showing renewed momentum as its growth engine—international expansion, a growing enterprise pipeline, and a ...
Broadcom sits at the crossroads of AI infrastructure and traditional networking. Here are three grounded predictions ...
When conviction runs hot but capital is capped, traditional 1:1 bets may feel limiting. The forget returns: double-le...
When Hamilton Beach reports earnings, investors gain clues about demand for small appliances and margin discipline. T...
In the crypto world, data is currency. This guide benchmarks privacy-respecting AI tools and shows how to use them to...
As accel acel 2025 earnings loom, investors seek clarity on revenue, margins, and guidance. This guide breaks down wh...
What could drive Entravision's 2025 earnings, and what should investors watch next? This guide breaks down the driver...
A single insider trade can spark headlines, but it isn’t a crystal ball. This guide explains how to read a director s...